BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31452145)

  • 1. Heteroplasmy Shifting as Therapy for Mitochondrial Disorders.
    Naeem MM; Sondheimer N
    Adv Exp Med Biol; 2019; 1158():257-267. PubMed ID: 31452145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches.
    Nissanka N; Moraes CT
    EMBO Rep; 2020 Mar; 21(3):e49612. PubMed ID: 32073748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances Towards Therapeutic Approaches for mtDNA Disease.
    Al Khatib I; Shutt TE
    Adv Exp Med Biol; 2019; 1158():217-246. PubMed ID: 31452143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Manipulation of mtDNA Heteroplasmy: A Shifting Perspective.
    Jackson CB; Turnbull DM; Minczuk M; Gammage PA
    Trends Mol Med; 2020 Jul; 26(7):698-709. PubMed ID: 32589937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of mtDNA heteroplasmy in mitochondrial replacement therapy by inducing forced mitophagy.
    Fan XY; Guo L; Chen LN; Yin S; Wen J; Li S; Ma JY; Jing T; Jiang MX; Sun XH; Chen M; Wang F; Wang ZB; Zhang CF; Wang XH; Ge ZJ; Hu C; Zeng L; Shen W; Sun QY; Ou XH; Luo SM
    Nat Biomed Eng; 2022 Apr; 6(4):339-350. PubMed ID: 35437313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current strategies towards therapeutic manipulation of mtDNA heteroplasmy.
    Pereira CV; Moraes CT
    Front Biosci (Landmark Ed); 2017 Jan; 22(6):991-1010. PubMed ID: 27814659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline transmission of donor, maternal and paternal mtDNA in primates.
    Ma H; Van Dyken C; Darby H; Mikhalchenko A; Marti-Gutierrez N; Koski A; Liang D; Li Y; Tippner-Hedges R; Kang E; Lee Y; Sidener H; Ramsey C; Hodge T; Amato P; Mitalipov S
    Hum Reprod; 2021 Jan; 36(2):493-505. PubMed ID: 33289786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations.
    Kang E; Wu J; Gutierrez NM; Koski A; Tippner-Hedges R; Agaronyan K; Platero-Luengo A; Martinez-Redondo P; Ma H; Lee Y; Hayama T; Van Dyken C; Wang X; Luo S; Ahmed R; Li Y; Ji D; Kayali R; Cinnioglu C; Olson S; Jensen J; Battaglia D; Lee D; Wu D; Huang T; Wolf DP; Temiakov D; Belmonte JC; Amato P; Mitalipov S
    Nature; 2016 Dec; 540(7632):270-275. PubMed ID: 27919073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating mitochondrial quality in disease transmission: towards enabling mitochondrial DNA disease carriers to have healthy children.
    Diot A; Dombi E; Lodge T; Liao C; Morten K; Carver J; Wells D; Child T; Johnston IG; Williams S; Poulton J
    Biochem Soc Trans; 2016 Aug; 44(4):1091-100. PubMed ID: 27528757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA.
    Tonin Y; Heckel AM; Dovydenko I; Meschaninova M; Comte C; Venyaminova A; Pyshnyi D; Tarassov I; Entelis N
    Biochimie; 2014 May; 100():192-9. PubMed ID: 23994754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial DNA Replacement Techniques to Prevent Human Mitochondrial Diseases.
    Sendra L; García-Mares A; Herrero MJ; Aliño SF
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430493
    [No Abstract]   [Full Text] [Related]  

  • 12. The distribution of mitochondrial DNA heteroplasmy due to random genetic drift.
    Wonnapinij P; Chinnery PF; Samuels DC
    Am J Hum Genet; 2008 Nov; 83(5):582-93. PubMed ID: 18976726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Inheritance Following Nuclear Transfer: From Cloned Animals to Patients with Mitochondrial Disease.
    Burgstaller JP; Chiaratti MR
    Methods Mol Biol; 2023; 2647():83-104. PubMed ID: 37041330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-quadruplex-mediated reduction of a pathogenic mitochondrial heteroplasmy.
    Naeem MM; Maheshan R; Costford SR; Wahedi A; Trajkovski M; Plavec J; Yatsunyk LA; Ciesielski GL; Kaufman BA; Sondheimer N
    Hum Mol Genet; 2019 Oct; 28(19):3163-3174. PubMed ID: 31261379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-editing enzymes as potential treatments for heteroplasmic mtDNA diseases.
    Zekonyte U; Bacman SR; Moraes CT
    J Intern Med; 2020 Jun; 287(6):685-697. PubMed ID: 32176378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease.
    Bayona-Bafaluy MP; Blits B; Battersby BJ; Shoubridge EA; Moraes CT
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14392-7. PubMed ID: 16179392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of mitochondrial DNA following assisted reproduction and nuclear transfer.
    Spikings EC; Alderson J; St John JC
    Hum Reprod Update; 2006; 12(4):401-15. PubMed ID: 16581809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput single cell analysis of mitochondrial heteroplasmy in mitochondrial diseases.
    Maeda R; Kami D; Maeda H; Shikuma A; Gojo S
    Sci Rep; 2020 Jul; 10(1):10821. PubMed ID: 32616755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive summary of mitochondrial DNA alterations in the postmortem human brain: A systematic review.
    Valiente-Pallejà A; Tortajada J; Bulduk BK; Vilella E; Garrabou G; Muntané G; Martorell L
    EBioMedicine; 2022 Feb; 76():103815. PubMed ID: 35085849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel reproductive technologies to prevent mitochondrial disease.
    Craven L; Tang MX; Gorman GS; De Sutter P; Heindryckx B
    Hum Reprod Update; 2017 Sep; 23(5):501-519. PubMed ID: 28651360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.